Modafinil Improves Real Driving Performance in Patients with Hypersomnia: A Randomized Double-Blind Placebo-Controlled Crossover Clinical Trial

Pierre Philip; Cyril Chaufton; Jacques Taillard; Aurore Capelli; Olivier Coste; Damien Léger; Nicholas Moore; Patricia Sagaspe

doi:10.5665/sleep.3480

Modafinil Improves Real Driving Performance in Patients with Hypersomnia: A Randomized Double-Blind Placebo-Controlled Crossover Clinical Trial

SLEEP ◽

10.5665/sleep.3480 ◽

2014 ◽

Vol 37 (3) ◽

pp. 483-487 ◽

Cited By ~ 47

Author(s):

Pierre Philip ◽

Cyril Chaufton ◽

Jacques Taillard ◽

Aurore Capelli ◽

Olivier Coste ◽

...

Keyword(s):

Clinical Trial ◽

Driving Performance ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol

Human Psychopharmacology Clinical and Experimental ◽

10.1002/hup.2749 ◽

2020 ◽

Vol 35 (5) ◽

Author(s):

Danielle McCartney ◽

Melissa J. Benson ◽

Anastasia S. Suraev ◽

Christopher Irwin ◽

Thomas R. Arkell ◽

...

Keyword(s):

Clinical Trial ◽

Driving Performance ◽

Trial Protocol ◽

Double Blind ◽

Double Blind Placebo ◽

Clinical Trial Protocol ◽

Dose Ranging ◽

Car Driving

Download Full-text

Test 1: Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Gene ◽

10.1016/s0378-1119(15)30104-4 ◽

2015 ◽

Author(s):

Jerry Lewis ◽

Lauren Bacall ◽

Humphrey Bogart ◽

Gene Kelly

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

British Homeopathic Journal ◽

10.1038/sj.bhj.5800206 ◽

1998 ◽

Vol 87 (2) ◽

pp. 86-88

Author(s):

D P Rastogi ◽

V P Singh ◽

Vikram Singh ◽

S K Dey ◽

K Rao

Keyword(s):

Clinical Trial ◽

Hiv Infection ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

Faculty Opinions recommendation of Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166121.627036 ◽

2009 ◽

Author(s):

Helen Kathryn Reddel ◽

Claude Farah

Keyword(s):

Clinical Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

Asthma Exacerbations ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1229980.697084 ◽

2009 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Faculty of 1000 evaluation for Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal® in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129305.793485934 ◽

2013 ◽

Author(s):

Iain Nixon ◽

Hannah Dixon

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Adenotonsillar Hypertrophy

Download Full-text

Oral Azitromycin Prophylaxis, 250 Mg Once Daily Three-Times a Week, in Primary Antibody Deficiencies: A Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3235640 ◽

2018 ◽

Author(s):

Cinzia Milito ◽

Federica Pulvirenti ◽

Francesco Cinetto ◽

Vassilios Lougaris ◽

Annarosa Soresina ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Primary Antibody ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Primary Antibody Deficiencies

Download Full-text

The Effects of Rasagiline on Glucose Metabolism and Cognition and Their Relationship to Tau Burden in a Double-Blind, Placebo-Controlled Phase Ii Clinical Trial of Participants with Alzheimer's Dementia

SSRN Electronic Journal ◽

10.2139/ssrn.3544838 ◽

2020 ◽

Author(s):

Dawn Matthews ◽

Aaron Ritter ◽

Ronald G. Thomas ◽

Randolph D. Andrews ◽

Ana S. Lukic ◽

...

Keyword(s):

Clinical Trial ◽

Glucose Metabolism ◽

Phase Ii ◽

Alzheimer’S Dementia ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Alzheimer's Dementia ◽

Double Blind Placebo

Download Full-text